Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.
Chung
K F
KF
National Heart & Lung Institute, Imperial College School of Medicine, London, UK.
Godard
P
P
Adelroth
E
E
Ayres
J
J
Barnes
N
N
Barnes
P
P
Bel
E
E
Burney
P
P
Chanez
P
P
Connett
G
G
Corrigan
C
C
de Blic
J
J
Fabbri
L
L
Holgate
S T
ST
Ind
P
P
Joos
G
G
Kerstjens
H
H
Leuenberger
P
P
Lofdahl
C G
CG
McKenzie
S
S
Magnussen
H
H
Postma
D
D
Saetta
M
M
Salmeron
S
S
Sterk
P
P
D000328:Adult; D000485:Allergens; D018927:Anti-Asthmatic Agents; D001249:Asthma / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D001993:Bronchodilator Agents; D002648:Child; D004781:Environmental Exposure; D006801:Humans
D000485:Allergens; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents